Article info
PDFOriginal research
Evidence supporting safe diagnosis of coeliac disease in children with antitissue transglutaminase titre ≥5 times upper limit of normal
- Correspondence to Dr Siba Prosad Paul, Paediatric Gastroenterology, Bristol Royal Hospital for Children, Bristol, BS2 8BJ, UK; siba.paul{at}nhs.net
Citation
Evidence supporting safe diagnosis of coeliac disease in children with antitissue transglutaminase titre ≥5 times upper limit of normal
Publication history
- Received March 8, 2021
- Accepted January 25, 2022
- First published February 16, 2022.
Online issue publication
October 18, 2023
Article Versions
- Previous version (15 November 2022).
- Previous version (15 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.